Amri

Albany Molecular Research Inc. (AMRI) is a global contract research and manufacturing organization. (Image: iStock/macgyverhh)

AMRI set to be acquired by private equity

By Melissa Fassbender

Private equity continues to make inroads in the contract research industry with two firms set to purchase AMRI in a deal worth $21.75 per share.

AMRI acquisitions driving up contract revenue in Q2

AMRI acquisitions driving up contract revenue in Q2

By Zachary Brennan

With contract revenue growth of nearly 40%, CDMO (contract development and manufacturing organization) AMRI is seeing its acquisitions of OsoBio, two Aptuit facilities and a UK aseptic facility pay off.

AMRI sets sights on acquiring Indian API manufacturer, CEO says

AMRI sets sights on acquiring Indian API manufacturer, CEO says

By Zachary Brennan

Following its three acquisitions over the last year, AMRI is now looking to extend its footprint into India further with the acquisition of a FDA-approved API site, William Marth, president and CEO of AMRI, told attendees at the Barclays Global Healthcare...

AMRI buys commercial manufacturer OsoBio for $110m

AMRI buys commercial manufacturer OsoBio for $110m

By Zachary Brennan

CMO (contract manufacturing organization) AMRI has agreed to acquire Oso Biopharmaceuticals Manufacturing for $110m in cash and thereby expand to late-stage and commercial product manufacturing. 

AMRI to acquire CDMO Cedarburg for $41M

AMRI to acquire CDMO Cedarburg for $41M

By Zachary Brennan

AMRI will acquire Cedarburg Pharmaceuticals for $38.2m (€27.7) in cash, plus $2.8m of assumed liabilities, to expand its API and drug development offerings.

AMRI Stock Tumbles After Announcing B-MS Trial Ends

AMRI Stock Tumbles After Announcing B-MS Trial Ends

By Zachary Brennan

Albany Molecular Research's (AMRI) stock fell more than 10% on Monday after announcing in an SEC filing that it was informed by its partner Bristol-Myers Squibb that it would terminate the development of an investigational depression drug.

Large Scale Manufacturing Drives AMRI Q1 Revenue Uptick

Large Scale Manufacturing Drives AMRI Q1 Revenue Uptick

By Zachary Brennan

Large scale manufacturing contract revenue in the first quarter of 2013 increased 14% over the same quarter in 2012 as AMRI (Albany Medical Research Inc.) saw an 11% increase in overall revenue. 

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers